1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 5, 02/Feb/2017
  4. Article
Research article Open Access
Like 0
Download

Abstract

To inform mathematical modelling of the impact of chlamydia screening in England since 2000, a complete picture of chlamydia testing is needed. Monitoring and surveillance systems evolved between 2000 and 2012. Since 2012, data on publicly funded chlamydia tests and diagnoses have been collected nationally. However, gaps exist for earlier years. We collated available data on chlamydia testing and diagnosis rates among 15–44-year-olds by sex and age group for 2000–2012. Where data were unavailable, we applied data- and evidence-based assumptions to construct plausible minimum and maximum estimates and set bounds on uncertainty. There was a large range between estimates in years when datasets were less comprehensive (2000–2008); smaller ranges were seen hereafter. In 15–19-year-old women in 2000, the estimated diagnosis rate ranged between 891 and 2,489 diagnoses per 100,000 persons. Testing and diagnosis rates increased between 2000 and 2012 in women and men across all age groups using minimum or maximum estimates, with greatest increases seen among 15–24-year-olds. Our dataset can be used to parameterise and validate mathematical models and serve as a reference dataset to which trends in chlamydia-related complications can be compared. Our analysis highlights the complexities of combining monitoring and surveillance datasets.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.5.30453
2017-02-02
2024-12-22
/content/10.2807/1560-7917.ES.2017.22.5.30453
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/5/eurosurv-22-5-5.html?itemId=/content/10.2807/1560-7917.ES.2017.22.5.30453&mimeType=html&fmt=ahah

References

  1. Public Health England (PHE). Table 8: Selected STI diagnoses and rates in the UK by gender and age group, 2009 to 2013. In: Sexually transmitted infections (STIs): annual data tables. London: PHE; 2014. [Accessed 2 Jun 2015]. Available from: https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables.
  2. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe 2013. 2015, Stockholm: ECDC. Available from: http://ecdc.europa.eu/en/publications/Publications/sexual-transmitted-infections-europe-surveillance-report-2013.pdf
  3. Public Health England (PHE). Opportunistic Chlamydia Screening of Young Adults in England - An Evidence Summary. London: PHE. 2014. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/497371/Opportunistic_Chlamydia_Screening_Evidence_Summary_April_2014.pdf
  4. Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1795-806.  https://doi.org/10.1016/S0140-6736(13)61947-9  PMID: 24286785 
  5. Klavs I, Rodrigues LC, Wellings K, Kese D, Hayes R. Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control. Sex Transm Infect. 2004;80(2):121-3.  https://doi.org/10.1136/sti.2003.005900  PMID: 15054174 
  6. van Bergen JE, Fennema JS, van den Broek IV, Brouwers EE, de Feijter EM, Hoebe CJ, et al. Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands. BMC Infect Dis. 2010;10(1):293.  https://doi.org/10.1186/1471-2334-10-293  PMID: 20925966 
  7. Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, et al. Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One. 2015;10(1):e0115753.  https://doi.org/10.1371/journal.pone.0115753  PMID: 25615574 
  8. van den Broek IV, Sfetcu O, van der Sande MA, Andersen B, Herrmann B, Ward H, et al. Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey. Eur J Public Health. 2016;26(3):382-8.  https://doi.org/10.1093/eurpub/ckv196  PMID: 26498953 
  9. Public Health England (PHE). National Chlamydia Screening Programme (NCSP). An overview of the National Chlamydia Screening Programme (NCSP). London: PHE. [Accessed 2 June 2015]. Available from: http://www.chlamydiascreening.nhs.uk/ps/overview.asp.
  10. Public Health England (PHE). National Chlamydia Screening Programme (NCSP). Chlamydia Testing Activity Dataset (CTAD). London: PHE. [Accessed 2 June 2015]. Available from: http://www.chlamydiascreening.nhs.uk/ps/info-management.asp.
  11. European Centre for Disease Prevention and Control (ECDC). Chlamydia control in Europe: literature review. Stockholm: ECDC. 2014. Available from: http://ecdc.europa.eu/en/publications/publications/chlamydia-control-europe.pdf
  12. Savage EJ, Mohammed H, Leong G, Duffell S, Hughes G. Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: the genitourinary medicine clinic activity dataset, England, 2009 to 2013. Euro Surveill. 2014;19(48):20981.  https://doi.org/10.2807/1560-7917.ES2014.19.48.20981  PMID: 25496573 
  13. Public Health England (PHE). Chlamydia Testing Activity Dataset - Dataset Specification and Technical Guidance version 3.0. 2014. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/493978/CTAD_Standard_publication_template_CT2a.pdf
  14. French CE, Hughes G, Nicholson A, Yung M, Ross JD, Williams T, et al. Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008. Sex Transm Dis. 2011;38(3):158-62.  https://doi.org/10.1097/OLQ.0b013e3181f22f3e  PMID: 21311319 
  15. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350(9084):1097-9.  https://doi.org/10.1016/S0140-6736(97)04248-7  PMID: 10213569 
  16. Kousoulis AA, Rafi I, de Lusignan S. The CPRD and the RCGP: building on research success by enhancing benefits for patients and practices. Br J Gen Pract. 2015;65(631):54-5.  https://doi.org/10.3399/bjgp15X683353  PMID: 25624277 
  17. Office for National Statistics [Internet]. [Accessed: 5 Jun 2015]. London: Office for National Statistics. Available from: http://www.ons.gov.uk/ons/index.html.
  18. Public Health England (PHE). Genitourinary Medicine Clinic Activity Dataset (version 2). Starter pack. London: PHE. 2015. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/420621/GUMCADv2_Starter_Pack_v3.pdf
  19. Public Health England (PHE). Genitourinary Medicine Clinic Activity Dataset (version 2). Technical guidance and extract specification for data extract. London: PHE. 2015. Available from: https://www.gov.uk/guidance/genitourinary-medicine-clinic-activity-dataset-gumcadv2
  20. Hughes G, Williams T, Simms I, Mercer C, Fenton K, Cassell J. Use of a primary care database to determine trends in genital chlamydia testing, diagnostic episodes and management in UK general practice, 1990-2004. Sex Transm Infect. 2007;83(4):310-3.  https://doi.org/10.1136/sti.2006.022673  PMID: 17360731 
  21. Chandrasekaran L, Davies B, Eaton JW, Ward H. Chlamydia diagnosis rate in England in 2012: an ecological study of local authorities. Sex Transm Infect. 2016;sextrans-2015-052441.  PMID: 27582249 
  22. Owusu-Edusei K Jr, Bohm MK, Chesson HW, Kent CK. Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analyses. Am J Prev Med. 2010;38(6):652-7.  https://doi.org/10.1016/j.amepre.2010.02.008  PMID: 20494242 
  23. Skidmore S, Horner P, Mallinson H. Testing specimens for Chlamydia trachomatis. Sex Transm Infect. 2006;82(4):272-5.  https://doi.org/10.1136/sti.2005.019034  PMID: 16877572 
  24. Martin DH, Nsuami M, Schachter J, Hook EW 3rd, Ferrero D, Quinn TC, et al. Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections. J Clin Microbiol. 2004;42(10):4749-58.  https://doi.org/10.1128/JCM.42.10.4749-4758.2004  PMID: 15472336 
  25. Woodhall SC. Has opportunistic screening among young adults in England led to a reduction in Chlamydia trachomatis infection? Identifying and appraising outcome measures for the evaluation of chlamydia control programmes. 2015. Thesis submitted for the degree of Doctor of Philosophy. University College London (UCL). Available from: http://discovery.ucl.ac.uk/1473893/1/Woodhall_PhD%20thesis_DEPOSITED.pdf
  26. National Audit Office (NAO). Young people's sexual health: the National Chlamydia Screening Programme. London: NAO. 2009. Available from: https://www.nao.org.uk/report/department-of-health-young-peoples-sexual-health-the-national-chlamydia-screening-programme/
Filling in the gaps: estimating numbers of chlamydia tests and diagnoses by age group and sex before and during the implementation of the English National Screening Programme, 2000 to 2012
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Nastassya+L+Chandra&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Chandra Nastassya L</a>, <a href="/search?value1=Kate+Soldan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Soldan Kate</a>, <a href="/search?value1=Ciara+Dangerfield&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Dangerfield Ciara</a>, <a href="/search?value1=Bersabeh+Sile&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sile Bersabeh</a>, <a href="/search?value1=Stephen+Duffell&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Duffell Stephen</a>, <a href="/search?value1=Alireza+Talebi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Talebi Alireza</a>, <a href="/search?value1=Yoon+H+Choi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Choi Yoon H</a>, <a href="/search?value1=Gwenda+Hughes&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hughes Gwenda</a>, <a href="/search?value1=Sarah+C+Woodhall&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Woodhall Sarah C</a></span>. Filling in the gaps: estimating numbers of chlamydia tests and diagnoses by age group and sex before and during the implementation of the English National Screening Programme, 2000 to 2012. <a href="/content/ecdc">Euro Surveill.</a> 2017;22(5):pii=30453. <a href="https://doi.org/10.2807/1560-7917.ES.2017.22.5.30453" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.5.30453</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 22 Jan 2016;&nbsp;&nbsp; <span class="generated">Accepted</span>: 04 Oct 2016 </span> </p>
/content/10.2807/1560-7917.ES.2017.22.5.30453
/content/10.2807/1560-7917.ES.2017.22.5.30453
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error